Treatment with rivaroxaban and ASA, after success­ful endovascular recanalization, in a subject with multi complicated peripheral arterial disease. Case report

Preserving the clinical result of revascularization in diabetic patients, usually affected by a complex and often progressive form of arteriop­athy, is a mandatory challenge to reduce major amputations rate and the related mortality rate as well. Low doses of the new NOAC anticoag­ulant drugs, more manageable than traditional coumarin drugs, if asso­ciated with ASA and / or clopidogrel, have shown a significant efficacy in thrombosis prevention, in subjects who underwent endovascular or surgical revascularization. Contraindications end cautions are neces­sary in subjects with ESRD, dialysis, mechanical prosthetic heart valves and old in age. KEY WORDS peripheral arterial disease; diabetes; thrombosis; anticoag­ulants.